Browse Items (31 total)
- Tags: Diabetes Mellitus
The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study.
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH
Tags: 2013, Acids, activation, Ahn S H, Alcohol, Alcohols, Bile, BILE acids, bound, cb1 receptors, Chanda D, Chiang J Y L, Choi H S, cholesterol 7-alpha-hydroxylase, Damage prevention, Deregulation, Diabetes Mellitus, element-binding protein, endocannabinoid system, endoplasmic-reticulum stress, er stress, exposure, Fatty Liver, gene-expression, Genes, hepatocytes, Homeostasis, human hepatocytes, insulin, insulin-resistance, Jeong W I, Journal Article or Conference Abstract Publication, Kim D K, Kim J R, Kim Y H, Koo S H, Kwon J, Lee C H, leptin resistance, Li T, Liver, Liver Diseases, Metabolism, Mice, Misra J, Muridae, Ohio, Park T S, PloS one, Regulatory mechanisms (biology), RNA extraction, Rodents, Science & Technology - Other Topics, Sciences: Comprehensive Works, Signal Transduction, Signaling, Synthesis, transcription factor
The Effect of Pharmacy-Led, Small-Group Academic Detailing on Prescribing Patterns in an Ambulatory Care Clinic.
Tags: 2019, Adrenergic Beta-Antagonists -- Therapeutic Use, Adult, Ambulatory Care Facilities, Awad Magdi H, Chi Square Test, Department of Pharmacy Practice, Descriptive Statistics, Diabetes Mellitus, Education, Essential Hypertension -- Drug Therapy, Fisher's Exact Test, Furdich Kenneth M, Gothard M David, Human, Hyperlipidemia -- Drug Therapy, Journal of Pharmacy Technology, June 2019 Update, Medically Underserved Area, Metformin -- Therapeutic Use, NEOMED College of Pharmacy, Non-Traditional, Outcomes of Education, Pharmacy Service, Physicians -- Education, Prescribing Patterns -- Education, Schneider Stacy R, Statins -- Therapeutic Use, Type 2 -- Drug Therapy, Ulbrich Timothy R
Pharmacists' role in glycemic management in the inpatient setting: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy.
Tags: 2019, Abla Alicia, Carneal Dustin, Department of Pharmacy Practice, Diabetes Mellitus, Donihi Amy C, Hanania Raja, hyperglycemia, hypoglycemia, Inpatients, JACCP: Journal of the American College of Clinical Pharmacy, June 2019 Update, MacMaster Heidemarie Windham, Moorman John M, NEOMED College of Pharmacy, Pharmacists
Glycoprotein Nonmelanoma Clone B Regulates the Crosstalk between Macrophages and Mesenchymal Stem Cells toward Wound Repair.
Tags: 2018, Administration, Alboslemy Talib, Animal, Animals, Cell Communication/*physiology, Cell Differentiation, Cells, Cultured, Cutaneous, Diabetes Mellitus, Disease Models, Eye Proteins/administration & dosage/genetics/*physiology, Humans, Inbred C57BL, Kim Min-Ho, Macrophages/*physiology, Male, Membrane Glycoproteins/administration & dosage/genetics/*physiology, Mesenchymal Stem Cells/*physiology, Mice, Recombinant Proteins/administration & dosage/genetics/metabolism, Safadi Fayez, Skin/*injuries/metabolism, The Journal of investigative dermatology, Type 2/complications/pathology, Wound Healing/*physiology, Yu Bing
Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center.
Tags: 2006, Academic Medical Centers, Age Factors, Aged, American journal of therapeutics, Angiotensin II Type I Receptor Blockers – Therapeutic Use, Angiotensin-Converting Enzyme Inhibitors – Therapeutic Use, Bourguet C C, Coronary Arteriosclerosis – Diagnosis, Department of Internal Medicine, Diabetes Mellitus, Diabetic Nephropathies – Diagnosis, Diabetic Nephropathies – Epidemiology, Diabetic Nephropathies – Etiology, Drug Utilization, Female, Frazee L A, Human, Hypertension – Diagnosis, Hypertension – Drug Therapy, Male, Middle Age, NEOMED College of Medicine, Pfister EW, Practice Guidelines, Professional Compliance, Proteinuria – Diagnosis, Retrospective Design, Samandari S, Tanphaichitr N, Type 1 – Complications, Type 1 – Drug Therapy, Type 2 – Complications, Type 2 – Drug Therapy
Improved A1C and Lipid Profile in Patients Referred to Diabetes Education Programs in a Wide Health Care Network: A Retrospective Study.
Tags: 2014, Aged, Analysis of Variance, Blood Pressure, Body Mass Index, Brateanu Andrei, Cholesterol – Blood, Confidence Intervals, Course Content, Creatinine, Diabetes Education, Diabetes Mellitus, Diabetes Spectrum, Female, Glomerular Filtration Rate, Glycosylated, HDL Cholesterol – Blood, Hemoglobin A, Human, LDL Cholesterol – Blood, Lipoproteins, Liu Louisa, Male, McNemar's Test, Middle Age, Min Jie Lee, Multivariate Analysis of Variance, Outcome Assessment, P-Value, Paired T-Tests, Primary Health Care, Retrospective Design, Triglycerides – Blood, Two-Tailed Test, Type 2 – Drug Therapy, Type 2 – Therapy
Hyperinsulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Trelat.
Tags: 2013, Acanthosis Nigricans/diagnosis/etiology/metabolism, Al-Shoha Ahmad, Brodell Robert T, Department of Internal Medicine, Diabetes Mellitus, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, Humans, NEOMED College of Medicine, Receptors, Saraiya Ami, Skin Diseases/diagnosis/*etiology/metabolism, Somatomedin/metabolism, Type 2/*complications/metabolism
Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.
Tags: 2018, Adult, Aged, Animal Studies, Animals, Apolipoprotein A-I/blood/*metabolism, Apolipoproteins – Blood, Apolipoproteins – Metabolism, Bena James, Biochemical Phenomena, Case Control Studies, Case-Control Studies, Cells, Comparative Studies, Cultured, Department of Pharmaceutical Sciences, Diabetes Mellitus, Diet, Dyslipidemias/complications/diet therapy/*metabolism, Evaluation Research, Female, Funding Source, Glycosylation, Golizeh Makan, HDL – Metabolism, HDL/*metabolism, Human, Humans, Hyperglycemia – Complications, Hyperglycemia – Diet Therapy, Hyperglycemia – Metabolism, Hyperglycemia/complications/diet therapy/*metabolism, Hyperlipidemia – Complications, Hyperlipidemia – Diet Therapy, Hyperlipidemia – Metabolism, Ilchenko Serguei, Kashyap Sangeeta R, Kasumov Takhar, Lee Kwangwon, Lipoproteins, Male, Mice, Middle Age, Middle Aged, Multicenter Studies, NEOMED College of Pharmacy, Osme Abdullah, Previs Stephen F, Protein Stability, Smith Jonathan D, The Journal of clinical endocrinology and metabolism, Type 2 – Complications, Type 2 – Diet Therapy, Type 2 – Metabolism, Type 2/complications/*diet therapy/metabolism, Validation Studies, Wang Shuhui
The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes.
Tags: *Diet, *Exercise Therapy, *Intensive medical therapy, *Myeloperoxidase, *Paraoxonase one, *Pro-inflammatory high-density lipoproteins, 2016, Adult, Apolipoprotein A-I/blood/drug effects, Bena James, Biguanides/pharmacology/therapeutic use, Combined Modality Therapy, Department of Pharmaceutical Sciences, Diabetes Mellitus, Diabetic, Female, HDL/blood/*drug effects, Humans, Hypoalphalipoproteinemias/complications/diet therapy/drug therapy/therapy, Hypoglycemic Agents/*pharmacology/therapeutic use, Insulin/analogs & derivatives/pharmacology/therapeutic use, Kashyap Sangeeta, Kasumov Takhar, Kheniser Karim, Li Ling, Lipids in health and disease, Lipoproteins, Male, Middle Aged, NEOMED College of Pharmacy, Retrospective Studies, Treatment Outcome, Type 2/blood/complications/*therapy
Tags: *Blood Pressure/drug effects, *Vasoconstriction/drug effects, 2011, Adrenergic alpha-Agonists/administration & dosage, American journal of physiology. Heart and circulatory physiology, Analysis of Variance, Animal, Animals, Azepines/administration & dosage, Biphenyl Compounds/administration & dosage, Bratz Ian N, Capsaicin/administration & dosage, Cells, Cultured, Damron Derek S, Department of Integrative Medical Sciences, Diabetes Mellitus, Diabetic Angiopathies/genetics/*metabolism/physiopathology, Dipeptides/administration & dosage, Disease Models, Dose-Response Relationship, Drug, Endothelial Cells/metabolism, Endothelin A Receptor Antagonists, Endothelin A/metabolism, Endothelin B Receptor Antagonists, Endothelin B/metabolism, Endothelin-1/*metabolism, Enzyme-Linked Immunosorbent Assay, Femoral Artery/drug effects/*metabolism/physiopathology, Guarini Giacinta, Haney Rebecca M, Inbred C57BL, Indoles/administration & dosage, Infusions, Intravenous, Knockout, Male, Meszaros J Gary, Mice, NEOMED College of Medicine, Ohanyan Vahagn A, Phenylephrine/administration & dosage, Raman Priya, Receptor, Talasila Phani K, Thodeti Charles K, TRPV Cation Channels/agonists/deficiency/genetics/*metabolism, Type 2/genetics/*metabolism/physiopathology, Vasoconstrictor Agents/administration & dosage
Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels.
Tags: 13-dienoic Acid/pharmacology, 15-Hydroxy-11 alpha, 2012, 9 alpha-(epoxymethano)prosta-5, American journal of physiology. Heart and circulatory physiology, Anilides/pharmacology, Animals, Bratz Ian N, Capsaicin/analogs & derivatives/pharmacology, Cinnamates/pharmacology, Coronary Vessels/drug effects/*metabolism/physiopathology, Damron Derek S, DelloStritto Daniel J, Department of Integrative Medical Sciences, Diabetes Mellitus, Diabetic Cardiomyopathies/drug therapy/*metabolism, Enzyme Inhibitors/pharmacology, Guarini Giacinta, Inbred C57BL, Kmetz John G, Large-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors/*metabolism, Male, Meszaros J Gary, Mice, Microvessels/drug effects/physiopathology, NEOMED College of Medicine, NG-Nitroarginine Methyl Ester/pharmacology, Nitric Oxide/*metabolism, Ohanyan Vahagn A, Peptides/pharmacology, Thodeti Charles K, Thoppil Roslin J, TRPV Cation Channels/agonists/antagonists & inhibitors/biosynthesis/*metabolism, Type 2/drug therapy/*metabolism, Vasoconstrictor Agents/pharmacology, Vasodilation/drug effects
Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium.
Tags: 2009, American journal of physiology. Endocrinology and metabolism, Animals, Blood Glucose/metabolism, Blotting, Body Weight/physiology, Cell Cycle Proteins/biosynthesis, Cell Cycle/*physiology, Cell Differentiation/physiology, Cell Proliferation, Cell Separation, Department of Integrative Medical Sciences, Diabetes Mellitus, Echocardiography, Experimental/pathology, Fibroblasts/*physiology, Hodson Ben R, Koshy John C, Luther Daniel J, Male, Meszaros J Gary, Microarray Analysis, Myocardium/cytology/*pathology, Myofibroblasts/*physiology, NEOMED College of Medicine, Ohanyan Vahagn, Phenotype, Rats, RNA/biosynthesis/isolation & purification, Shamhart Patricia E, Signal Transduction/physiology, Sprague-Dawley, Type 1/diagnostic imaging/*pathology, Western
Tags: 2015, Bile Acids and Salts/*metabolism, Biological Transport, Chiang John Y L, Cholesterol 7-alpha-Hydroxylase/metabolism, Current opinion in gastroenterology, Cytoplasmic and Nuclear/metabolism, Department of Integrative Medical Sciences, Diabetes Mellitus, Energy Metabolism, Homeostasis, Humans, Inflammation/*metabolism, Intestine, Li Tiangang, Liver/*metabolism/pathology, NEOMED College of Medicine, Obesity/*metabolism, Receptors, Signal Transduction, Small/*metabolism/pathology, Type 2/*metabolism
Evaluation of factors associated with achieving glycemic control in a pharmacist-managed diabetes clinic.
Tags: 2014, Ambulatory Care, Ambulatory Care/organization & administration, American journal of therapeutics, Blood Glucose – Drug Effects, Blood Glucose/drug effects, Boros Melanie L, Department of Internal Medicine, Department of Pharmaceutical Sciences, Department of Pharmacy Practice, Diabetes Mellitus, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Frazee Lawrence A, Glycated Hemoglobin A/metabolism, Glycosylated – Metabolism, Hemoglobin A, Human, Humans, Hypoglycemic Agents – Administration and Dosage, Hypoglycemic Agents – Therapeutic Use, Hypoglycemic Agents/administration & dosage/*therapeutic use, Insulin – Administration and Dosage, Insulin – Therapeutic Use, Insulin/administration & dosage/therapeutic use, Kostoff Matthew D, Male, Middle Age, Middle Aged, Moorman John M, NEOMED College of Medicine, NEOMED College of Pharmacy, Pharmaceutical Services/*organization & administration, Pharmacists – Administration, Pharmacists/*organization & administration, Pharmacy Service – Administration, Prospective Studies, Retrospective Design, Retrospective Studies, Social Work – Statistics and Numerical Data, Social Work/statistics & numerical data, Treatment Outcome, Treatment Outcomes, Type 2 – Drug Therapy, Type 2/*drug therapy
Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center.
Tags: *Guideline Adherence, 2006, Academic Medical Centers, Age Factors, Aged, American journal of therapeutics, Angiotensin II Type 1 Receptor Blockers/*administration & dosage/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/*administration & dosage/therapeutic use, Bourguet Claire C, Coronary Artery Disease/diagnosis, Department of Internal Medicine, Diabetes Mellitus, Diabetic Nephropathies/*diagnosis/epidemiology/etiology, Drug Utilization, Female, Frazee Lawrence A, Humans, Hypertension/diagnosis/drug therapy, Male, Middle Aged, NEOMED College of Medicine, Pfister Eugene W, Practice Guidelines as Topic, Proteinuria/diagnosis, Retrospective Studies, Samandari Seyhoon, Tanphaichitr Natthavat, Type 1/complications/drug therapy, Type 2/complications/drug therapy
Tags: *Cosmetic Techniques/adverse effects, *Lipectomy, *Patient Satisfaction, 2001, Abdominal Muscles/*surgery, Adolescent, Adult, Aged, Annals of plastic surgery, Diabetes Mellitus, Female, Hensel J M, Humans, Hypertension, Lehman J A Jr, Male, Middle Aged, Outcome Assessment (Health Care), Parker M G, Reoperation, Retrospective Studies, Risk Factors, Smoking, Tantri M P, Topham N S, Wagner D S
Retinoic acid-related orphan receptor alpha regulates diurnal rhythm and fasting induction of sterol 12alpha-hydroxylase in bile acid synthesis.
Tags: 2013, Animals, Bile Acids and Salts/*biosynthesis, Chiang John Y L, Cholesterol, Cholesterol/*biosynthesis/genetics, Circadian Rhythm/*physiology, Department of Integrative Medical Sciences, Diabetes, Diabetes Mellitus, Enzyme Induction/physiology, Fasting/*metabolism, Fatty Liver/drug therapy/genetics/metabolism/pathology, Group F, Hep G2 Cells, Humans, Li Tiangang, Lipid Metabolism, Member 1/genetics/*metabolism, Mice, NEOMED College of Medicine, Non-alcoholic Fatty Liver Disease, Nuclear Receptor Subfamily 1, Nuclear Receptors, Obesity, Pathak Preeti, Phosphorylation/physiology, Protein Kinases/genetics/metabolism, Response Elements/physiology, Steroid 12-alpha-Hydroxylase/*biosynthesis/genetics, The Journal of biological chemistry, Type 2/drug therapy/genetics/metabolism/pathology
Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.
Tags: *Gene Expression Regulation, 2012, Animals, Bile Acids and Salts/*biosynthesis, Boehme Shannon, Chiang John Y L, Cholesterol 7-alpha-Hydroxylase/genetics/*metabolism, Cytoplasmic and Nuclear/genetics/metabolism, Department of Integrative Medical Sciences, Diabetes Mellitus, Dietary Fats/administration & dosage/adverse effects, Enzymologic, Epigenesis, Erickson Sandra K, Experimental/genetics/*metabolism, Fasting/metabolism, Francl Jessica M, Genetic/genetics, Glucose/*metabolism/pharmacology, Insulin/*metabolism, Klaassen Curtis D, Li Tiangang, Mice, NEOMED College of Medicine, Obesity/etiology/genetics/*metabolism, Ochoa Adrian, Postprandial Period/genetics, Receptors, Sweetening Agents/pharmacology, The Journal of biological chemistry, Transgenic, Zhang Youcai
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Tags: 1999, Adult, American journal of kidney diseases : the official journal of the National Kidney Foundation, Angiotensin-Converting Enzyme Inhibitors/*therapeutic use, Antihypertensive Agents/*therapeutic use, Bain R P, Blood Pressure/drug effects, Blumenthal S, Captopril/*therapeutic use, Cattran D, Chronic/etiology, Creatinine/blood, Department of Internal Medicine, Diabetes Mellitus, Diabetic Nephropathies/*drug therapy/physiopathology, Disease Progression, Female, Follow-Up Studies, Hebert L A, Humans, Kidney Failure, Levey A S, Lewis E J, Lewis J B, Male, Middle Aged, NEOMED College of Medicine, Nephrotic Syndrome/complications/*drug therapy/physiopathology, Prospective Studies, Proteinuria, Randomized Controlled Trials as Topic, Remission Induction, Rohde R D, Spitalewitz S, Type 1/*complications, Whittier F, Wilmer W A
Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE(-/-) mice.
Tags: 2017, Animals, Aorta/drug effects/metabolism, Apolipoproteins E/*metabolism, Atherosclerosis/*drug therapy/metabolism, Chavez Ronaldo J, Department of Integrative Medical Sciences, Diabetes Mellitus, Diabetic Angiopathies/drug therapy/metabolism, Experimental/chemically induced/drug therapy/metabolism, Ganguly Rituparna, Glucose/metabolism, Glycosylation/drug effects, Haney Rebecca, Hyperglycemia/*drug therapy/metabolism, Inbred C57BL, Knockout, Male, Mice, Myocytes, NEOMED College of Medicine, NEOMED Student Publications, Ohanyan Vahagn, Picolinic Acids/*pharmacology, Raman Priya, Sahu Soumyadip, Scientific reports, Shah Shivani, Smooth Muscle/drug effects, Streptozocin/*pharmacology, Thrombospondin 1/*metabolism, Type 1/chemically induced/*drug therapy/metabolism, Yalamanchili Siri
Tags: 2015, Animals, Apolipoproteins E/genetics, Atherosclerosis/genetics/metabolism, Department of Integrative Medical Sciences, Diabetes Mellitus, Experimental/genetics/metabolism, Hep G2 Cells, Hepatocyte Nuclear Factor 4/*genetics/metabolism, Humans, Knockout, LDL/genetics, Li Yuanyuan, Lipid Metabolism/*genetics, Lipoproteins/metabolism, Liver/metabolism, Mice, MicroRNAs/*genetics/metabolism, Middle Aged, Nature communications, NEOMED College of Medicine, Non-alcoholic Fatty Liver Disease/*genetics/metabolism, Physiological/*genetics, Receptors, Stress, Triglycerides/*metabolism, Xu Jiesi, Xu Yang, Yin Liya, Zalzala Munaf, Zhang Yanqiao
Tags: 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation, Biological Availability, Cadaver, Chronic/surgery, Cyclosporine/administration & dosage/*pharmacokinetics, Diabetes Mellitus, Diabetic Nephropathies/surgery, Fisher R K, Flechner S M, Haug M, Humans, Immunosuppressive Agents/administration & dosage/*pharmacokinetics, Injections, Intravenous, Kidney Failure, Kidney Function Tests, Kidney Transplantation/*physiology, Male, Middle Aged, Modlin C S, Morbid/etiology/*physiopathology, Obesity, Type 1/complications
Tags: 1996, Aging/physiology, Animals, Blood Glucose/metabolism, Body Composition/*physiology, Body Weight/physiology, Chandler M P, Collins H L, Cortright R N, Diabetes Mellitus, DiCarlo S E, Experimental/*physiopathology, Female, Growth/*physiology, Inbred Lew, Lemon P W, Male, Physiology & behavior, Rats, Sex Characteristics
Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.
Tags: *Ceruloplasmin, *Deamidation, *Heavy water metabolic labeling, *High resolution mass spectrometry, *Iron metabolism, *LC-MS/MS, *Non-enzymatic glycation, *Oxidative Stress, *Protein Processing, *Proteome dynamics, *Serotransferrin, *Type 2 diabetes mellitus, 2017, Adult, Amino Acid Sequence, Bena James, Case-Control Studies, Ceruloplasmin/genetics/*metabolism, Department of Pharmaceutical Sciences, Deuterium/metabolism, Diabetes Mellitus, Diabetic, Diet, Female, Free radical biology & medicine, Gene Expression Regulation, Glycated Hemoglobin A/genetics/metabolism, Glycosylation, Golizeh Makan, Humans, Ilchenko Serguei, Iron/*metabolism, Isotope Labeling, Kashyap Sangeeta R, Kasumov Takhar, Lee Kwangwon, Male, Middle Aged, NEOMED College of Pharmacy, Osme Abdullah, Oxidation-Reduction, Oxidative Stress, Post-Translational, Proteolysis, Sadygov Rovshan G, Transferrin/genetics/*metabolism, Type 2/diet therapy/genetics/*metabolism/pathology
Tags: *Axon regeneration, *Axotomy, *Diabetes, *Neuropathy, *Peripheral nervous system, 2017, Animal, Animals, Antibiotics, Antineoplastic/toxicity, Blood Glucose/drug effects, Body Weight/drug effects, Crish Samuel D, Cytokine Receptor gp130/genetics/*metabolism, Cytokines/metabolism, DeFrancesco Alicia, Department of Pharmaceutical Sciences, Diabetes Mellitus, Disease Models, Experimental neurology, Experimental/chemically induced/complications/*pathology, Fasting/blood, Filous Angela R, Gene Expression Regulation/*physiology, Hyperalgesia/etiology, Hyperglycemia/etiology, Inbred C57BL, Lindborg Jane A, Male, Malhotra Nisha A, Mice, NEOMED College of Pharmacy, Nerve Degeneration/*etiology/pathology, Nerve Tissue Proteins/metabolism, Niemi Jon P, Pain Measurement, Signal Transduction/drug effects/*physiology, Streptozocin/toxicity, Superior Cervical Ganglion/drug effects/*metabolism, Sweating/drug effects, Wilson Gina N, Zhou Bowen, Zigmond Richard E
Overcoming missed opportunities in diabetes management to improve outcomes for hospitalized patients with diabetes.
Tags: 2018, Aged, Blood Glucose/*metabolism, Clough Lynn, Cohort Studies, Cudnik Michelle L, Department of Internal Medicine, Department of Pharmaceutical Sciences, Department of Pharmacy Practice, Diabetes Mellitus, Diabetes research and clinical practice, Elavsky Megan, Female, Glycated Hemoglobin A/*metabolism, Hospitalization, Humans, Kunz Jason, Male, Middle Aged, NEOMED College of Medicine, NEOMED College of Pharmacy, Oravec Michael, Retrospective Studies, Salem James, Treatment Outcome, Type 2/*drug therapy, Woods Robert
Prevalence and Predictors of Metformin Prescribing in Adults with Type 2 Diabetes Mellitus: A National Cross-Sectional Study.
Tags: *evidence-based medicine, *metformin, *predictors, *prescribing, 2016, Adolescent, Adult, Aged, Boyle Jaclyn A, Cross-Sectional Studies, Dengler-Crish Christine M, Department of Pharmaceutical Sciences, Department of Pharmacy Practice, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents/*therapeutic use, Logistic Models, Male, Metformin/*therapeutic use, Middle Aged, Moorman John M, NEOMED College of Pharmacy, Pharmacotherapy, Prevalence, Soric Mate M, Type 2/*drug therapy
Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.
Tags: 2017, Akinrotimi Oludemilade, Anakk Sayeepriyadarshini, Animals, Body Weight/genetics, Cytoplasmic and Nuclear/*physiology, Department of Integrative Medical Sciences, Diabetes Mellitus, Fatty Liver/*genetics, Hepatology (Baltimore, Md.), Knockout, Lee Yoon-Kwang, Lipid Metabolism/genetics, Mice, NEOMED College of Medicine, Park Jung Eun, Receptors, Riessen Ryan, Schoonjans Kristina, Type 2/*genetics, VanDuyne Philip, Wong Lee-Jun, Zavacki Ann M
Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Tags: *Lipid Metabolism, 2016, Adiposity, Animals, Carboxylesterase/*metabolism, Carboxylic Ester Hydrolases/genetics/*metabolism, Department of Integrative Medical Sciences, Department of Pharmaceutical Sciences, Diabetes Mellitus, Diet, Endoplasmic Reticulum Stress, Energy Metabolism, Experimental/enzymology, Gene Knockdown Techniques, Glucose Tolerance Test, Glucose/metabolism, Hepatocyte Nuclear Factor 4/*metabolism, Hepatology (Baltimore, Md.), High-Fat/adverse effects, Homeostasis, Humans, Inbred C57BL, Jadhav Kavita, Kasumov Takhar, Li Yuanyuan, Lipogenesis, Lipolysis, Liver/enzymology, Male, Mice, NEOMED College of Medicine, NEOMED College of Pharmacy, Non-alcoholic Fatty Liver Disease/*etiology/metabolism, Obesity/enzymology/etiology, Sterol Regulatory Element Binding Protein 1/metabolism, Xu Yang, Yin Liya, Zalzala Munaf, Zhang Yanqiao